NIH Funding Boost Clears Senate Committee

The proposed spending increase in the draft bill is more generous than that in the House version.

By | September 6, 2017

Senate buildingRON COGSWELL, FLICKRFor the third year in a row, the Senate Labor, Health and Human Services, and Education Appropriations Subcommittee has approved a $2 billion increase to the National Institutes of Health’s annual budget, ScienceInsider reports. The proposal, which would increase the budget by 6 percent over the current fiscal year, stands in contrast to that of President Donald Trump’s request—an 18 percent cut—and a House panel’s plan, which included a 3.2 percent increase.

The Senate measure includes increases in funding for some specific programs, such as a brain-mapping initiative and a large precision medicine study. It rejects Trump’s suggestion to cap indirect cost payments to 10 percent of the grant amount.

In a statement about the spending bill, Research!America CEO Mary Woolley says, “As Alzheimer’s disease, cancer, and the opioid epidemic impact the health and economic security of communities across the country, additional funding is desperately needed to advance innovative research that will deepen our understanding of the root causes of disease and addiction.”

ScienceInsider reports that the draft bill will next be considered by the full Senate appropriations committee. If it passes the Senate, it will need to be reconciled with the House version.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.